DTIL Precision Biosciences Inc

Price (delayed)

$10.52

Market cap

$72.76M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$15.96

Enterprise value

-$35.06M

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome ...

Highlights

DTIL's debt has shrunk by 65% YoY

DTIL's EPS has soared by 58% year-on-year and by 16% since the previous quarter

Precision Biosciences's gross profit has soared by 94% YoY but it has decreased by 7% from the previous quarter

Precision Biosciences's revenue has soared by 94% YoY but it has decreased by 7% from the previous quarter

The company's equity has shrunk by 69% YoY and by 35% QoQ

Precision Biosciences's quick ratio has decreased by 19% YoY and by 4.8% QoQ

Sector: Healthcare

Industry: Biotechnology

Website: http://precisionbiosciences.com

Peers: OMER OMGA

Key stats

What are the main financial stats of DTIL

Market

Shares outstanding

6.92M

Market cap

$72.76M

Enterprise value

-$35.06M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

2.21

Price to sales (P/S)

0.83

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

-0.72

Earnings

Revenue

$48.73M

EBIT

-$59.09M

EBITDA

-$50.83M

Free cash flow

-$85.96M

Per share

EPS

-$15.96

Free cash flow per share

-$22.38

Book value per share

$4.76

Revenue per share

$12.68

TBVPS

$41.49

Balance sheet

Total assets

$159.78M

Total liabilities

$140.92M

Debt

$8.86M

Equity

$18.86M

Working capital

$86.37M

Liquidity

Debt to equity

0.47

Current ratio

2.73

Quick ratio

2.59

Net debt/EBITDA

2.12

Margins

EBITDA margin

-104.3%

Gross margin

100%

Net margin

-125.8%

Operating margin

-89.8%

Efficiency

Return on assets

-34.5%

Return on equity

-200.8%

Return on invested capital

-2,413.8%

Return on capital employed

-53.8%

Return on sales

-121.3%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

DTIL stock price

How has the Precision Biosciences stock price performed over time

Intraday

-2.95%

1 week

12.15%

1 month

-31.87%

1 year

-57.24%

YTD

-3.93%

QTD

-22.42%

Financial performance

How have Precision Biosciences's revenue and profit performed over time

Revenue

$48.73M

Gross profit

$48.73M

Operating income

-$43.74M

Net income

-$61.32M

Gross margin

100%

Net margin

-125.8%

Precision Biosciences's gross profit has soared by 94% YoY but it has decreased by 7% from the previous quarter

Precision Biosciences's revenue has soared by 94% YoY but it has decreased by 7% from the previous quarter

DTIL's net margin has soared by 72% YoY and by 11% QoQ

The operating margin has soared by 64% year-on-year and by 23% since the previous quarter

Growth

What is Precision Biosciences's growth rate over time

Valuation

What is Precision Biosciences stock price valuation

P/E

N/A

P/B

2.21

P/S

0.83

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

-0.72

DTIL's EPS has soared by 58% year-on-year and by 16% since the previous quarter

The company's equity has shrunk by 69% YoY and by 35% QoQ

DTIL's P/B is 46% below its 5-year quarterly average of 4.1 but 16% above its last 4 quarters average of 1.9

Precision Biosciences's revenue has soared by 94% YoY but it has decreased by 7% from the previous quarter

The P/S is 92% lower than the 5-year quarterly average of 10.9 and 41% lower than the last 4 quarters average of 1.4

Efficiency

How efficient is Precision Biosciences business performance

The return on invested capital has dropped by 81% since the previous quarter

DTIL's ROS has soared by 72% year-on-year and by 11% since the previous quarter

Precision Biosciences's return on equity has decreased by 43% YoY and by 12% QoQ

Precision Biosciences's ROA has increased by 24% YoY and by 8% from the previous quarter

Dividends

What is DTIL's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for DTIL.

Financial health

How did Precision Biosciences financials performed over time

Precision Biosciences's total assets is 13% more than its total liabilities

Precision Biosciences's total assets has decreased by 33% YoY and by 2.8% from the previous quarter

The total liabilities is down by 21% year-on-year but it is up by 4.2% since the previous quarter

DTIL's debt is 53% lower than its equity

The company's equity has shrunk by 69% YoY and by 35% QoQ

DTIL's debt has shrunk by 65% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.